N. Moitessier et al. / Tetrahedron 61 (2005) 6839–6853
6851
1574 cmK1; 1H NMR (250 MHz, CDCl3) d 8.42 (d, 1H, JZ
3.5 Hz), 7.38 (2dd, 2H, JZ8.0, 8.0 Hz), 7.08–6.90 (m,
11H), 6.81 (d, 1H, JZ7.5 Hz), 6.40 (bs, 1H), 3.15 (m, 4H),
2.35 (s, 6H); 13C NMR (65 MHz, CDCl3) d 162.2, 160.5,
158.6, 148.9, 143.4, 136.4, 136.3, 135.9, 128.2, 127.7,
122.8, 121.1, 120.8, 119.9, 80.0, 37.1, 37.0, 20.7; LRMS
(EIC, m/z, %): 395 (18) (MCHC), 394 (72) (MC), 303
(88), 156 (88), 119 (90), 91 (100) (TolC); HRMS (m/z):
[MCH]C calcd for C27H27N2O 395.2123, found 395.2131.
procedure as for compound 1p, alcohol 10b (401 mg,
1.02 mmol) in water (10 mL) and conc. HCl (1 mL) led to a
white powder that was reacted with AcCl (4 mL) and SOCl2
(6 mL) then with pyranoside 1a (1.1 g, 5.7 mmol) in
pyridine (20 mL) to afford, after chromatography
(CH2Cl2/MeOH, 49:1 then 19:1), compound 1r (265 mg,
50%) along with recovered alcohol 10b (115 mg, 29%);
RfZ0.48 (CH2Cl2/MeOH, 9:1); [a]DC0.5 (c 0.8, CHCl3);
mp 72 8C; IR (neat/NaCl) 3401, 1586, 1574 cmK1; 1H NMR
(250 MHz, CDCl3) d 7.47 (dd, 1H, JZ7.5, 8.0 Hz), 7.31
(d, 1H, JZ8.0 Hz), 7.29–7.08 (m, 13H), 6.91 (d, 1H, JZ
7.5 Hz), 6.75 (s, 1H), 4.71 (d, 1H, JZ3.5 Hz), 3.88–3.80 (m,
2H), 3.76 (m, 1H), 3.64 (ddd, 1H, JZ3.5, 9.0, 9.0 Hz), 3.41
(ddd, 1H, JZ3.5, 9.0 Hz), 3.34 (s, 3H), 3.20 (ddd, 1H, JZ
5.0, 9.0 Hz), 3.13 (dd, 2H, JZ6.5, 8.0 Hz), 2.98 (dd, 2H,
JZ6.5, 8.0 Hz), 2.82 (s, 1H), 2.35 (s, 6H), 2.28 (d, 1H, JZ
9.0 Hz); 13C NMR (65 MHz, CDCl3) d 161.5, 160.6, 141.1,
140.3, 140.1, 137.2, 137.1, 136.6, 129.1, 128.9, 128.6,
128.5, 128.2, 125.8, 122.2, 121.3, 99.5, 86.8, 74.0, 72.9,
72.3, 69.8, 65.9, 55.3, 39.3, 36.5, 21.0; LRMS (EIC, m/z,
%): 570 (14) (MCHC), 569 (27) (MC), 393 (25), 392 (88),
377 (100) (PGCHC), 376 (60) (PGC), 376 (100)
(PGKHC), 284 (72), 119 (83), 91 (63) (TolC); HRMS
(m/z): [MCH]C calcd for C35H40NO6 570.2855, found
570.2903.
4.2.9. (6-Phenethyl-pyridin-2-yl)-di-p-tolyl-methanol
(10b). Using the same procedure as for alcohol 10a, a
solution of olefin 9b (480 mg, 1.09 mmol) in EtOH (25 mL)
afforded, after chromatography (H/EA, 1:0 then 9:1) alcohol
10b (403 mg, 94%, colorless oil); RfZ0.68 (H/EA, 4:1); IR
1
(neat/NaCl) 3378, 1591, 1574 cmK1; H NMR (250 MHz,
CDCl3) d 7.50 (dd, 1H, JZ7.5, 8.0 Hz), 7.28–7.16 (m, 5H),
7.18 (d, 2H, JZ7.5 Hz), 7.12 (d, 2H, JZ7.5 Hz), 6.99
(d, 1H, JZ7.5 Hz), 6.93 (d, 1H, JZ8.0 Hz), 6.61 (s, 1H),
3.18–3.03 (m, 4H), 2.35(s, 6H);13C NMR (65 MHz, CDCl3) d
162.4, 158.9, 143.6, 141.2, 136.6, 136.5, 128.4, 128.2, 128.0,
125.8, 121.4, 120.2, 80.2, 39.4, 35.2, 20.9; LRMS (EIC, m/z,
%): 394 (11) (MCHC), 393 (49) (MC), 302 (45), 156 (48),
119 (76), 91 (100) (TolC); HRMS (m/z): [MCH]C calcd for
C28H28NO 394.2171, found 394.2445.
4.2.10. Methyl 6-O-[6-(2-Pyridin-2-yl-ethyl)-pyridin-2-
yl]-di-p-tolyl-methyl-a-D-glucopyranoside (1q). A sus-
pension of alcohol 10a (910 mg, 2.3 mmol) in water
(18 mL) and conc. HCl (2 mL) was refluxed for 1 h. The
resulting mixture was concentrated and the residue
precipitated in ether. A solution of this white powder in
AcCl (4 mL) and SOCl2 (6 mL) both freshly distilled was
stirred for 48 h then concentrated at rt and co-evaporated
twice with toluene. To the crude alkyl chloride 11a was
added a solution of pyranoside 1a (1.8 g, 9.2 mmol) in
pyridine (40 mL) and the mixture was stirred for 48 h,
concentrated, extracted with CH2Cl2, filtrated, washed with
water and brine, dried over Na2SO4 and concentrated in
vacuo. The residue was purified by chromatography
(CH2Cl2/MeOH, from 49:1 to 9:1) to afford protected
compound 1q (820 mg, 63%, white powder) along with
recovered alcohol 10a (205 mg, 23%); RfZ0.39 (CH2Cl2/
MeOH, 9:1); [a]DC56.0 (c 0.3, CHCl3); mp 92 8C; IR
4.3. Optimized synthesis of compound 10a
4.3.1. 6-Pyridin-2-ylethynyl-pyridine-2-carboxylic acid
methyl ester (15). To a solution of bromopicolinic acid
methyl ester 14 (1.88 g, 8.7 mmol.) and 2-ethynylpyridine
in a mixture of triethylamine and THF (80 mL, 1:1) were
added copper iodide (33 mg, 0.17 mmol) and PdCl2(PPh3)2
(244 mg, 0.35 mmol). The resulting mixture was heated to
60 8C and stirred for 2 h. The solid suspension was filtered,
concentrated in vacuo and the residue was purified by flash
chromatography (H/A/CH2Cl2, 4:1:1 then 1:4:1) to afford
compound 15 (1.99 g, 96%, light yellow solid); RfZ0.40
(EA); IR (neat/NaCl) 1718 cmK1 1H NMR (400 MHz,
;
CDCl3) d 8.61 (d, 1H, JZ4.5 Hz), 8.08 (dd, 1H, JZ1.5,
7.0 Hz), 7.84 (dd, 1H, JZ8.0, 8.0 Hz), 7.80–7.58 (m, 3H),
7.26 (m, 1H), 3.97 (s, 3H); 13C NMR (65 MHz, CDCl3) d
164.2, 149.5, 147.6, 142.0, 141.5, 136.9, 135.6, 130.1,
127.1, 123.9, 123.0, 88.1, 86.4, 52.3; LRMS (EIC, m/z, %):
261.5 (100) (MCNaC), 239.5 (66) (MCHC); Anal. calcd
for C14H10N2O2: C, 70.58; H, 4.23; N, 11.76; found: C,
70.47; H, 4.22. N, 11.54.
1
(neat/NaCl) 3400, 1589, 1573 cmK1; H NMR (250 MHz,
CDCl3) d 8.59 (dd, 1H, JZ1.5, 5.5 Hz), 7.55 (ddd, 1H, JZ
1.5, 8.0, 8.0 Hz), 7.53 (dd, 1H, JZ8.0, 8.0 Hz), 7.38 (d, 2H,
JZ8.0 Hz), 7.28 (d, 2H, JZ8.0 Hz), 7.26 (dd, 1H, JZ5.5,
8.0 Hz), 7.17–7.09 (m, 6H), 7.05 (d, 1H, JZ7.5 Hz), 4.71
(d, 1H, JZ3.5 Hz), 4.70 (bs, 1H), 3.94 (m, 1H), 3.85 (m,
2H), 3.65 (m, 1H), 3.35 (s, 3H), 3.33–3.05 (m, 6H), 2.37 (s,
3H), 2.33 (s, 3H), 2.29 (d, 1H, JZ9.5 Hz); 13C NMR
(65 MHz, CDCl3) d 161.7, 160.6, 160.3, 149.2, 141.1,
139.3, 137.3, 136.8, 136.5, 129.5, 128.4, 128.3, 123.1,
122.2, 121.3, 121.2, 99.5, 86.9, 73.7, 73.5, 72.6, 69.7, 66.7,
55.2, 38.9, 38.0, 20.9; LRMS (EIC, m/z, %): 571 (2) (MC
HC), 570 (5) (MC), 394 (21), 393 (76), 378 (69) (PGCHC),
377 (56) (PGC), 376 (100) (PGKHC), 284 (75), 119 (50),
91 (36) (TolC); HRMS (m/z): [MCH]C calcd for
C34H39N2O6 571.2808, found 571.2796.
4.3.2. 6-(2-Pyridin-2-yl-ethyl)-pyridine-2-carboxylic
acid methyl ester (16). A suspension of ester 15 (1.94 g,
8.15 mmol) and 10% Pd/C (1.9 g) was stirred for 24 h under
hydrogen, filtered and concentrated in vacuo. The residue
was next purified by chromatography (CH2/Cl2/MeOH, 99:1
then 94:6) to afford compound 16 (1.78 g, 90%, light yellow
solid); RfZ0.48 (CH2Cl2/MeOH); IR (neat/NaCl) 1740,
1723 cmK1; 1H NMR (400 MHz, CDCl3) d 8.55 (d, 1H, JZ
4.5 Hz), 7.96 (d, 1H, JZ8.0 Hz), 7.70 (dd, 1H, JZ8.0,
8.0 Hz), 7.56 (ddd, 1H, JZ2.0, 8.0, 8.0 Hz), 7.30 (d, 1H,
JZ8.0 Hz), 7.12 (m, 2H), 4.01 (s, 3H), 3.38 (m, 2H), 3.26
(m, 2H); 13C NMR (65 MHz, CDCl3) d 165.8, 161.6, 160.5,
149.1, 147.4, 137.0, 136.1, 126.3, 122.9, 122.6, 121.1, 52.7,
37.8, 37.7; LRMS (EIC, m/z, %): 265.5 (32) (MCNaC),
4.2.11. Methyl 6-O-[6-phenethyl-pyridin-2-yl]-di-p-tolyl-
methyl-a-D-glucopyranoside (1r). Following the same